Gregory Ferenstein
Gregory Ferenstein is a senior fellow in drug policy at Reason Foundation.
-
Governor Polis signed Colorado’s restrictive AI law, but supports a federal moratorium on similar legislation
Governor Polis believes it would be best to have a strong national policy governing AI that supersedes state law.
-
California needs tech solutions, not just poorly defined AI regulations, to protect kids
California’s Assembly Bill 1064 attempts to regulate a problem—dangerous AI-driven attachments— without clear solutions.
-
Congress attempts to standardize AI rules, but legal challenges remain
If well designed, a uniform federal framework could offer clarity and help artificial intelligence technologies flourish.
-
The App Store Accountability Act attempts to regulate unproven technology
The bill would require major application platforms to verify that underage users have affirmative parental consent for each app download and purchase.
-
Psychedelics Policy Newsletter: Reforms for Congress, data for rescheduling, and more
Plus: State regulation progress and more.
-
State psychedelics legalization and policy roundup — April 2025
State efforts to legalize psychedelic therapies have made strides during the 2025 legislative sessions.
-
Oregon House Bill 2387 would improve psilocybin services
The bill includes important regulatory improvements to Ballot Measure 109, which created the state’s psilocybin services market.
-
Exploring new data on the safety of psychedelics
Reason Foundation’s recently published psychedelics dashboard offers a clearer picture of how psilocybin access is affecting communities.
-
Legislative approaches that could improve access to psychedelic-based medicine
Psychedelics-assisted therapy represents a promising treatment for many mental health issues.
-
Psychedelics Policy Newsletter: States propose legalization, optimism for Trump administration nominee, and more
Plus: A policy brief on psychedelics and neurodegenerative treatments, alternatives to 'double-blind' trials, and more.
-
State psychedelics legalization and policy roundup — February 2025
New York proposes a medical retail model, Colorado opens for business, and more.
-
Psychedelics Policy Newsletter: Trump administration recommendations, Massachusetts loss, and more
Plus: Government funding for addiction research, veteran’s administration pursues psychedelics, and more.
-
State psychedelics legalization and policy roundup — December 2024
Possible psychedelic reform on the horizon, a ballot initiative in Massachusetts fails, and more.
-
Psychedelic drug policy recommendations for the incoming Trump administration
The incoming Trump administration has promised sweeping reforms, and that might include reversing the federal suppression of psychedelics.
-
Psilocybin access would improve mental health care in Massachusetts
Ballot Question 4 would create a regulated framework for legal, professionally facilitated psychedelic services and therapy.
-
Psychedelics Policy Newsletter: MDMA rejection, advocating for lower state fees in Colorado, and more
Plus: A profile of ibogaine advocate Bryan Hubbard, the Drug Enforcement Administration head worries about ketamine, and more.
-
State psychedelics legalization and policy roundup — September 2024
A Massachusetts ballot initiative moves forward, Colorado considers high business application and renewal fees, and more.
-
Colorado should rethink proposed psychedelic application fees
There are several areas where the draft permanent rules on fees for psychedelic applications proposed by the Colorado Department of Revenue could be enhanced.
